Take your research to the next level
Peiyuan Lin, Ph.D.
Senior Vice President, HD Biosciences
Peiyuan Lin joined HD Biosciences (a WuXi AppTec subsidiary company) as Senior Vice President in 2008, leading R&D efforts in drug discovery. Dr. Lin earned her Ph.D. in molecular pharmacology from the University of Cincinnati College of Medicine in 1988. Since then, she has gained extensive knowledge and experience working internationally over the last 30 years in both pharmaceutical drug discovery and the CRO industry.
Qingyang Gu, Ph.D.
Head of Oncology & Immunology Unit (OIU)
Dr. Qingyang Gu joined WuXi AppTec in 2012. He has been dedicated to working in the fields of tumor biology, anti-tumor therapeutics development, and translational medicine for more than two decades, in which he has gained a wealth of experience and expertise in biomedical sciences and team management.
Declan Ryan, Ph.D.
Vice President, US Business Development
Over 20 years' experience in R&D in both research and business development roles at 3-Dimensional Pharmaceuticals, Novartis, Johnson & Johnson, AMRI and Shanghai ChemPartner. Declan Ryan earned his Ph.D. from the University of Lausanne, Switzerland, and he completed postdoctoral studies at Yale University and the University of Pittsburgh, USA.
Dave Madge, Ph.D.
Vice President, EU and Israel BD Head
Over 20 years’ experience working within academia, biotech and CRO companies. Dave Madge is the former VP Research at Xention, founder of NCE Discovery (now Domainex) and a member of the integrated biomedical research group at University College London. Dave started his career at the Wellcome Foundation and received his Ph.D. in chemistry from Imperial College, London.